Inhibition of Apoptosis and Proliferation in T Cells by Immunosuppressive Silymarine
Abstract
Keywords
Full Text:
PDFReferences
- Wattenberg L. Inhibition of Carcinogenesis by Naturally-Occurring and Synthetic Compounds. In: Kuroda Y, Shankel D, Waters M, editors. Antimutagenesis and Anticarcinogenesis Mechanisms II. Basic Life Sciences. 52: Springer US; 1990. p. 155-66.
- Valenzuela A, Garrido A. Biochemical bases of the pharmacological action of the flavonoid silymarin and of its structural isomer silibinin. Biol Res. 1994;27(2):105-12.
- Ahmed B, Ahmed B, Khan SA, Alam T. Synthesis and antihepatotoxic activity of some heterocyclic compounds containing the 1,4-dioxane ring system. Die Pharmazie - An International Journal of Pharmaceutical Sciences. 2003;58(3):173-6.
- Ball KR, Kowdley KV. A Review of Silybum marianum (Milk Thistle) as a Treatment for Alcoholic Liver Disease. Journal of Clinical Gastroenterology. 2005;39(6):520-8.
- Gazak R, Walterova D, Kren V. Silybin and silymarin--new and emerging applications in medicine. Curr Med Chem. 2007;14(3):315-38.
- Saller R, Meier R, Brignoli R. The Use of Silymarin in the Treatment of Liver Diseases. Drugs. 2001;61(14):2035-63.
- Polyak SJ, Morishima C, Shuhart MC, Wang CC, Liu Y, Lee DYW. Inhibition of T-Cell Inflammatory Cytokines, Hepatocyte NF-κB Signaling, and HCV Infection by Standardized Silymarin. Gastroenterology. 2007;132(5):1925.
- Alidoost F, Gharagozloo M, Bagherpour B, Jafarian A, Sajjadi SE, Hourfar H, et al. Effects of silymarin on the proliferation and glutathione levels of peripheral blood mononuclear cells from β-thalassemia major patients. International Immunopharmacology. 2006;6(8):1305-10.
- Gharagozloo M, Javid EN, Rezaei A, Mousavizadeh K. Silymarin inhibits cell cycle progression and mTOR activity in activated human T cells: therapeutic implications for autoimmune diseases. Basic & clinical pharmacology & toxicology. 2013;112(4):251-6.
- Wilasrusmee C, Kittur S, Shah G, Siddiqui J, Bruch D, Wilasrus- mee S et al. Immunostimulatory effect of Silybum marianum (milk thistle) extract. Med Sci Monit 2002;8:BR439–43.
- Gharagozloo M, Velardi E, Bruscoli S, Agostini M, Di Sante M, Donato V et al. Silymarin suppress CD4+ T cell activation and proliferation: effects on NF-kappaB activity and IL-2 production. Pharmacol Res 2010;61:405–9. 10
- Gharagozloo M, Javid EN, Rezaei A, Mousavizadeh K. Silymarin inhibits cell cycle progression and mTOR activity in activated human T cells: therapeutic implications for autoimmune diseases. Basic Clin Pharmacol Toxicol 2012;12:251–6. 11
- Morishima C, Shuhart MC, Wang CC, Paschal DM, Apodaca MC, Liu Y et al. Silymarin inhibits in vitro T-cell proliferation and cytokine production in hepatitis C virus infection. Gastroenterology 2010;138:671–81.
- Frohn C, Fricke L, Puchta JC, Kirchner H. The effect of HLA‐C matching on acute renal transplant rejection. Nephrology Dialysis Transplantation. 2001;16(2):355-60.
- Gharagozloo M, Velardi E, Bruscoli S, Agostini M, Di Sante M, Donato V, et al. Silymarin suppress CD4+ T cell activation and proliferation: Effects on NF-κB activity and IL-2 production. Pharmacological Research. 2010;61(5):405-9.
- Schümann J, Prockl J, Kiemer AK, Vollmar AM, Bang R, Tiegs G. Silibinin protects mice from T cell-dependent liver injury. Journal of Hepatology. 2003;39(3):333-40.
- Meroni PL, Barcellini W, Borghi MO, Vismara A, Ferraro G, Ciani D, et al. Silybin inhibition of human T-lymphocyte activation. Int J Tissue React. 1988;10(3):177-81.
- Morishima C, Shuhart MC, Wang CC, Paschal DM, Apodaca MC, Liu Y, et al. Silymarin Inhibits In Vitro T-Cell Proliferation and Cytokine Production in Hepatitis C Virus Infection. Gastroenterology. 2010;138(2):671-81.e2.
- Cruz T, Galvez J, Crespo E, Ocete MA, Zarzuelo A. Effects of silymarin on the acute stage of the trinitrobenzenesulphonic acid model of rat colitis. PlantaMed 2001;67(1):94–6.
- Johnson VJ, He Q, Osuchowski MF, Sharma RP. Physiological responses of a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice: III. Silymarin inhibits T-lymphocyte function at low doses but stimulates inflammatory processes at high doses. Planta Med 2003;69(1):44–9.
- Gharagozloo M, Javid EN, Rezaei A, Mousavizadeh K. Silymarin inhibits cell cycle progression and mTOR activity in activated human T cells: therapeutic implications for autoimmune diseases. Basic & clinical pharmacology & toxicology. 2013;112(4):251-6.
- Gharagozloo M, Jafari S, Esmaeil N, Javid EN, Bagherpour B, Rezaei A. Immunosuppressive effect of silymarin on mitogen-activated protein kinase signalling pathway: the impact on T cell proliferation and cytokine production. Basic & clinical pharmacology & toxicology. 2013;113(3):209-14.
- Thornberry N and Lazebnik Y: Caspases: enemies within. Science 281: 1312-1316, 1998.
- Degen WG, Pruijn GJ, Raats JM and van Venrooij WJ: Caspase-dependent cleavage of nucleic acids. Cell Death Differ 7: 616-627, 2000
- Slee EA, Adrian C and Martin SJ: Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ 6: 1067-1074, 1999
- Huppertz B, Frank H-G and Kaufmann P: The apoptosis cascade – morphological and immunohistochemical methods for its visualization. Anat Embryol 200: 1-18,1999.
- Herr I and Debatin KM: Cellular stress response and apoptosis in cancer therapy. Blood 98: 2603-2614, 2001.
- Debatin KM: Anticancer drugs, programmed cell death and the immune system: defining new roles in an old play. J Natl Cancer Inst 89: 750-753, 1997.
- Jagtap, P.; Szabo, C. Poly. (ADP-ribose) polymerase and the therapeutic effects of its inhibitors. Nat. Rev. Drug Discov. 2005, 4, 421–440.
Refbacks
- There are currently no refbacks.
Iranian Journal of Allergy, Asthma and Immunology (Bimonthly), pISSN: 1735-1502, eISSN: 1735-5249
Tehran University of Medical Sciences, Tehran, Iran.
|